Exhibitor announcements at Advanced Therapies Europe
Explore the latest announcements from exhibitors at Advanced Therapies Europe. This curated library features company updates, investment news, awards, product developments, and expert insights from organizations shaping the future of cell and gene therapy. Whether you're tracking emerging partnerships, innovative technologies, or strategic milestones, this page brings together stories from the showfloor to keep you informed and connected to the pulse of the advanced therapies industry.
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
)
Explore the latest analytical strategies for AAV characterisation and learn how to optimise your viral vector development. -
)
Intertek's cell and gene therapy experts provide analytical development to help you meet regulatory expectations for safety and efficacy of your products. -
)
Strengthening expertise in inhaled drug laboratory solutions. New bioassay and cell culture units will bring additional capabilities for cell-based potency assays. -
)
Join us for a ground-breaking and insightful forum on inhaled and nasal biologics or inhaled vaccine development. -
)
VIVEbiotech celebrates 10 years of innovation, growth, and global impact in lentiviral vector manufacturing, marking a decade of excellence in gene therapy support. -
)
VIVEbiotech secures growth investment from Ampersand Capital to expand lentiviral vector manufacturing and support global gene and cell therapy development. -
VIVEbiotech wins “CMO/CDMO of the Year” at the Advanced Therapies Awards, recognizing our excellence and innovation in gene therapy manufacturing. A proud start to 2025!